Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer. Kung CP, Cottrell KA, Ryu S, Bramel ER, et al. Oncogene 2020 Oct 27. pii: 10.1038/s41388-020-01515.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kung CP, Cottrell KA, Ryu S, Bramel ER, et al. Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer. Oncogene 2020 Oct 27. pii: 10.1038/s41388-020-01515.
PMID: 33110236